Skip to main content

Advertisement

Log in

Recent advances in osteoclast biology

  • Review
  • Published:
Histochemistry and Cell Biology Aims and scope Submit manuscript

Abstract

The bone is an essential organ for locomotion and protection of the body, as well as hematopoiesis and mineral homeostasis. In order to exert these functions throughout life, bone tissue undergoes a repeating cycle of osteoclastic bone resorption and osteoblastic bone formation. The osteoclast is a large, multinucleated cell that is differentiated from monocyte/macrophage lineage cells by macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-κB ligand (RANKL). RANKL transduces its signal through the signaling receptor, RANK. RANKL/RANK signaling activates NFATc1, the master regulator of osteoclastogenesis, to induce osteoclastogenic gene expression. Many types of cells express RANKL to support osteoclastogenesis depending on the biological context and the dysregulation of RANKL signaling leads to bone diseases such as osteoporosis and osteopetrosis. This review outlines the findings on osteoclast and RANKL/RANK signaling that have accumulated to date.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Download references

Acknowledgements

This work was supported by Ichiro Kanehara Foundation, Lotte Research Promotion Grant, Takeda Science Foundation, The Uehara Memorial Foundation, Japan Agency for Medical Research and Development (AMED, award number: JP17gm0810003), Japan Society for the Promotion of Science (JSPS), Naito Foundation, Astellas Foundation for Research on Metabolic Disorders, Sumitomo Foundation, Asahi Glass Foundation, Daiichi Sankyo Foundation of Life Science, Secom Science and Technology Foundation (SSTF), Mochida Memorial Foundation for Medical and Pharmaceutical Research, Terumo Foundation and Matsui Life Social Welfare Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takehito Ono.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ono, T., Nakashima, T. Recent advances in osteoclast biology. Histochem Cell Biol 149, 325–341 (2018). https://doi.org/10.1007/s00418-018-1636-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00418-018-1636-2

Keywords

Navigation